Inspect an author's raw data, methods, and reproducibility across their publications.
Press Enter ↵ to find
Explore by Goal
"The molecules of life are like letters of the alphabet. You can't tell what a word says by knowing the number of letters in it."
- Matt Ridley
Quick Explanation
Copied
Sudipta Show — evidence-rich but uneven rigor
Across multiple subjects (G-quadruplex/i-motif DNA biophysics, nanozyme/redox nanomaterials, osteocyte–adiponectin signaling, platelet phosphoproteomics, and microbial/environmental studies), the author’s work is often multi-assay and mechanism-oriented, but several studies show common weaknesses: limited in vivo validation, small sample sizes, incomplete public raw-data deposition, and occasional over-reliance on in vitro/in silico proxies. Examples include G4 ligand stabilization with multi-biophysical readouts and redox-biased ceria nanozymes with Zn/Cu dopants tuned by Ce3+/surface chemistry and enzyme-mimetic ROS readouts . Where phosphoproteomics is concerned, at least one paper provides explicit raw-data deposition (PRIDE PXD000451), strengthening verifiability . Overall: strong experimental breadth and cross-validation tendencies, but variable rigor and limited external generalizability." evidence-strength="moderate">
Long Explanation
Author Review: Sudipta Show
What I can and cannot verify: I attempted to retrieve author-level citation metrics via OpenAlex, but the OpenAlex API returned a 503 Service Unavailable error (so citation counts are not verifiable from that source here). Therefore, this review focuses on the scientific structure and verifiable experimental claims contained in the provided raw-data paper extracts.
Evidence-anchored snapshot (what recurs across works)
Multi-method triangulation is common (e.g., spectroscopic + binding/functional assays + simulation). Example: flexible vs rigid G4 ligands combine CD melting/titration, ThT displacement, FID, Taq stop assays, and MD to argue mechanism .
In vitro-first or model-driven scope appears frequently (DNA oligos without cells; nanozyme experiments without in vivo toxicology; osteocyte biology with mouse/in vitro context but still limited translational depth in many summaries). Example limitations are explicitly mentioned for several studies .
Reproducibility & data transparency vary: some works provide public raw-data identifiers (strong), while others indicate “available on request” or do not clearly deposit trajectories/raw spectra (weaker). Example: platelet phosphoproteomics includes PRIDE PXD000451 , while several other extracted entries note no explicit repository deposition .
Key quantitative figures (from the provided raw extracts)
Below graphs are built only from the numerical values present in the supplied extraction.
(1) G-quadruplex stabilization: ΔTm (ribosomal G4 vs telomeric G4)
Interpretation (strictly evidence-limited): the extract reports ΔTm values for multiple ligands on ribosomal and telomeric G4 structures, with some compounds showing increases up to ~17 °C on ribosomal G4 and ~11 °C on telomeric G4. This is part of a larger multi-assay stabilization argument .
(2) Ceria nanozymes: IC50 selectivity (MCF-7 vs HUVEC) as reported
Strict caveat: the extract provides SI for selected formulations; a single plot mixes IC50 and SI units for visualization only, so do not treat it as a combined metric. The underlying paper links dopant identity/level to altered Ce3+ fractions and enzyme-mimetic ROS processing, and reports selectivity between MCF-7 and HUVEC in vitro .
Strength: This extract reports explicit PRIDE deposition and mechanistic axis testing via CD36 blockade and kinase inhibitors .
Limitation: the extract notes that discovery datasets used single biological replicates per agonist, so confidence in differential phosphorylation magnitudes requires extra caution .
Scientific critique: strengths, blind spots, and what would change my view
Strengths
Mechanism-seeking across assays: DNA ligand papers combine binding/stabilization functional readouts with mechanistic MD contact explanations (flexibility changing interaction landscapes) .
Some datasets are verifiable: PRIDE deposition in the platelet phosphoproteomics paper improves auditability relative to studies that only state “data available on request” .
Occasional translational scaffolding: osteocyte–adiponectin findings use genetic and pharmacologic perturbation of PPARG with in vivo and in vitro components, though still with known translational limits .
Blind spots / recurring vulnerabilities
Generalizability gaps: Several studies are confined to in vitro systems or limited in vivo windows/strains. For nanozymes, mechanisms are frequently inferred rather than directly measured intracellularly .
Public raw-data variability: where raw trajectories, instrument spectra, or full processed intermediate artifacts are not deposited, independent verification is weaker. G4 ligand study indicates supporting information without clear accession numbers in the provided excerpt .
Calibration/proxy risk: spectroscopy-derived proxies (e.g., CD Tm shifts; UV/fluorescence binding constants in acidic conditions for i-motif studies) can be sensitive to experimental conditions and assumptions about stoichiometry/environment. For example, i-motif binding work explicitly uses acidic pH to stabilize iM and relies on spectroscopic proxies .
Model dependence: MD and thermodynamic interpretations depend on force fields, sampling time, parameterization, and definitions of hydration/binding layers. The hydration-layer MD paper uses CHARMM22/TIP3P and relatively short timescales, limiting confident generalization beyond HP-36 .
What would change my confidence (clear disconfirming tests)
Replicate across wider biological context: for DNA binding/stabilization, demonstrate consistent effects across multiple G4/iM sequences and in cellular contexts rather than only a few templates .
Direct mechanism measurement: for nanozymes, directly measure intracellular ROS species and oxygen vacancy-related biomarkers rather than only inferring from enzyme-mimetic activity in vitro .
Increase statistical robustness: discovery phosphoproteomics is often underpowered when only a single replicate is used for discovery; increasing replicate numbers and confirming candidate sites would strengthen causal pathway confidence .
Overall evaluation (scientific epistemic balance)
Known / supported by provided extracts: the author’s body of work (as represented by the provided extracts) often integrates multiple experimental modalities and, in some cases, includes public data deposition (e.g., PRIDE for platelet phosphoproteomics).
Uncertain / needs stronger external validation: cross-domain generalization (DNA templates, cell lines, dopant distributions), physiological relevance (assay condition dependence), and intracellular mechanistic verification (for nanozyme ROS) remain partially unresolved. .
Most plausible pattern: the author demonstrates the ability to conduct and integrate experimental and computational analyses, but the rigor and verifiability are not uniform across all topics; where raw-data deposition and replication are weaker, epistemic confidence should be tempered.
Note on scope
This review is constrained to the paper-level raw extracts provided in the prompt. It does not establish the author’s full publication record or overall citation performance, since author-level bibliometrics were inaccessible (OpenAlex API error).
Parse the extracted IC50/SI and ΔTm values, compute ranking tables (potency vs selectivity vs stabilization), and render Plotly comparison plots for rapid cross-paper skepticism checks.
Get emailed when your analysis is done!
We'll email you the results when your analysis is finished.
Hypothesis Graveyard
“End-stacking alone explains all observed G4 stabilization” is unlikely if flexible scaffolds show broader remodeling/contact patterns beyond end stacking in MD plus multiple orthogonal assays.
“Nanozyme selectivity will persist uniformly across environments” is doubtful because aggregation/protein corona and intracellular ROS context can plausibly flip effective redox bias, and the extracts note inferential intracellular linkage and in vitro scope.
Explore by Goal
Quick Explanation
Long Explanation
Top Data Sources
Ask a Follow-Up
Key Insight
Keep Exploring
Analysis 
Hypothesis Graveyard
Potential Experiments
Discussion